Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

CME Group to offer 24/7 trading for Ethereum and other crypto futures from May 29, 2026, pending approval

Market News
29 May 2026
Crypto Briefing
View Source
Bullish
pluang ai news

CME Group will launch nearly 24/7 trading for its crypto futures and options, including Ethereum, starting May 29, 2026, pending regulatory approval. This move eliminates weekend trading gaps, allowing institutional traders continuous access to Bitcoin, Ethereum, and other altcoin derivatives on a regulated platform. Trades executed over weekends will be assigned the next business day for settlement, maintaining current clearing processes. The expansion responds to rising demand and enhances hedging options for Ethereum-based financial products, improving risk management for investors.

More News

YieldMax to close and liquidate four ETFs by June 18, 2026, focusing on stronger funds.

YieldMax to close and liquidate four ETFs by June 18, 2026, focusing on stronger funds.

YieldMax announced it will close and liquidate four ETFs—ABNY, DISO, FEAT, and FIVY—by June 18, 2026, following a portfolio review. The decision aims to concentrate resources on ETFs with higher investor demand and better market traction. Trading for...

Company Fundamentals
Bearish
1 hour ago
Canborsa launches beta of first perpetual DEX for tokenized real-world assets with up to 20x leverage.

Canborsa launches beta of first perpetual DEX for tokenized real-world assets with up to 20x leverage.

Canborsa has launched the beta version of its decentralized exchange (DEX) on the Canton Network, enabling non-custodial perpetual trading of tokenized real-world assets like stocks, gold, oil, and cryptocurrencies with up to 20x leverage. The platfo...

Others
Bullish
1 hour ago
Oculis' Phase 3 trials for OCS-01 in diabetic macular edema fail primary vision improvement endpoint.

Oculis' Phase 3 trials for OCS-01 in diabetic macular edema fail primary vision improvement endpoint.

Oculis announced that its Phase 3 DIAMOND trials for OCS-01 eye drops in diabetic macular edema did not meet the primary endpoint of improved visual acuity after 52 weeks. However, the treatment showed significant and lasting reduction in retinal thi...

Company Fundamentals
Bearish
2 hours ago
Allied Gold receives key regulatory approvals, extends deal deadline with Zijin Gold to July 29, 2026.

Allied Gold receives key regulatory approvals, extends deal deadline with Zijin Gold to July 29, 2026.

Allied Gold Corporation announced that Zijin Gold has received approval under the Investment Canada Act for its proposed acquisition of Allied Gold. This approval completes the Canadian regulatory process for the transaction. The deal has also cleare...

Company Fundamentals
Bullish
2 hours ago
Kentucky First Federal Bancorp may resume quarterly dividends up to $0.10 per share after a special board meeting on July 28, 2026.

Kentucky First Federal Bancorp may resume quarterly dividends up to $0.10 per share after a special board meeting on July 28, 2026.

Kentucky First Federal Bancorp announced a special board meeting on July 28, 2026, to consider resuming quarterly dividends on its common stock, potentially up to $0.10 per share. The company has suspended dividends since November 2023, and no final ...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App